Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Biological Psychiatry|January 6, 2018
Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine AddictionAlan J Cross, Robert Anthenelli, Xia LiPsychopharmacology|December 21, 2016
From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disordersJane B Acri, Alan J Cross, Phil SkolnickNeuropharmacology|February 4, 2014
Quantification of the interrelationships of receptor pharmacologies within a tricyclic privileged structural scaffold through application of modified forward selectionMichael W Wood, Steven S Wesolowski, Daniel V Widzowski, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 25, 2016
The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in RatsEric Augier, Russell S Dulman, Caroline Rauffenbart, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2004
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP miceMei-Ping Kung, Catherine Hou, Zhi-Ping Zhuang, et al.British Journal of Clinical Pharmacology|May 8, 2014
The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy malesXia Chen, Gabriël Jacobs, Marieke de Kam, et al.Journal of Clinical Psychopharmacology|December 11, 2014
AZD6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteersXia Chen, Gabriel Jacobs, Marieke L de Kam, et al.Biological Psychiatry|March 25, 2015
The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel MonkeysZuzana Justinova, Leigh V Panlilio, Maria E Secci, et al.BMC Genomics|June 23, 2019
Comprehensive assessment of multiple biases in small RNA sequencing reveals significant differences in the performance of widely used methodsCarrie Wright, Anandita Rajpurohit, Emily E Burke, et al.Clinical Pharmacology in Drug Development|April 30, 2016
The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levelsErik T Te Beek, Xia Chen, Gabriël E Jacobs, et al.Pageof 2